Oruka Therapeutics, Inc. · NASDAQ:ORKA
Quinlan Paul T sold 52,000 Oruka Therapeutics, Inc. shares (Form 4)
Traded Aug 14, 2026 · Filed Aug 14, 2026
On Aug 14, 2026, Quinlan Paul T (General Counsel) sold 52,000 Oruka Therapeutics, Inc. shares at an average US$108.49 for US$5.64M under a trading plan, leaving 31,034 shares. Filed Aug 14, 2026 (Form 4).
- Sold
- 52,000 shares
- Price
- US$108.49 average (US$106.05 to US$111.14)
- Value
- US$5.64M
- Holding after
- 31,034 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- General Counsel
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Common Stock | Option exercise | 10,000 | US$7.80 | 41,034 | Direct |
| Aug 14, 2026 | Common Stock | Option exercise | 42,000 | US$12.50 | 83,034 | Direct |
| Aug 14, 2026 | Common Stock | Sale | 3,630 | US$106.05 | 79,404 | Direct |
| Aug 14, 2026 | Common Stock | Sale | 10,434 | US$107.14 | 68,970 | Direct |
| Aug 14, 2026 | Common Stock | Sale | 14,696 | US$107.97 | 54,274 | Direct |
| Aug 14, 2026 | Common Stock | Sale | 10,200 | US$109.11 | 44,074 | Direct |
| Aug 14, 2026 | Common Stock | Sale | 9,193 | US$110.00 | 34,881 | Direct |
| Aug 14, 2026 | Common Stock | Sale | 3,847 | US$111.14 | 31,034 | Direct |
Source
Related
- Oruka Therapeutics, Inc.
- Quinlan Paul T
- Oruka Therapeutics, Inc. shareholders
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026
- Form 4 · Quinlan Paul T · Sep 15, 2026
- Form 4 · Quinlan Paul T · Jun 15, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Agarwal Arjun · Sep 21, 2026
- Form 4 · Goncalves Joana · Sep 15, 2026